A Translational Systems Medicine Approach to Provide Predictive Capacity for Therapy Response in Advanced or Metastatic Malignant Melanoma

Clinical trial NCT02177110 · COMPLETED

Trial details

NCT number: NCT02177110
Sponsor: Cancer Trials Ireland
Status: COMPLETED
Study type: OBSERVATIONAL

Advanced Melanoma Metastatic Melanoma

Start date: 2014-09-01
Primary completion: 2020-08-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.